Caring Brands (CABR) Long-Term Deferred Tax (2024 - 2025)
Caring Brands (CABR) posted quarterly Long-Term Deferred Tax of $647029.0 for Q3 2025, up 257.11% quarter-over-quarter from $181186.0 in Q4 2024.
Caring Brands (CABR) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
Caring Brands' Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $647029.0 for Q3 2025.
- In Q3 2025, Long-Term Deferred Tax changed N/A year-over-year to $647029.0; the TTM figure through Sep 2025 stood at $647029.0 (changed N/A YoY), while the FY2024 annual figure was $181186.0, changed N/A from the prior year.
- Long-Term Deferred Tax for Q3 2025 stood at $647029.0, up from $181186.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $647029.0 in Q3 2025, with the low at $181186.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Caring Brands | 11.69 Mn | 9.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 647,029.00 |
| Dec 31, 2024 | 181,186.00 |